Scleroderma

Scleroderma, or systemic sclerosis, is an unending connective tissue malady for the most part delegated one of the immune system rheumatic sicknesses. It can include scarring, vein issues, shifting degrees of irritation, and is related with an overactive resistant framework, solidifying and fixing of the skin and connective tissues. Finding depends on clinical indications, however tests and strategies might be utilized initiallly to avoid elective determinations, and later for appraisal of organ inclusion and observing of ailment movement. Exploratory treatments under scrutiny incorporate endothelin receptor antagonsits,tyrosine kinase inhibitors, beta-glycan peptides, halofuginone, basiliximab, alemtuzumab, abatacept and haematopoietic undeveloped cell transplantation.

  • Track 1-1 Sign and Symptoms
  • Track 2-2 Progressive Systemic Sclerosis
  • Track 3-3 CREST Syndrome
  • Track 4-4 Morphea
  • Track 5-5 Linear Scleroderma
  • Track 6-6 Diffuse Scleroderma
  • Track 7-7 Limited Scleroderma
  • Track 8-8 Pathophysiology
  • Track 9-9 Treatment

Related Conference of Surgery